<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:07:49Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/13284" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/13284</identifier><datestamp>2026-10-18T21:13:26Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Case report: Cerebral thromboembolism in an unconscious covid-19 patient in intensive care</dc:title><dc:creator>Unver, Edhem</dc:creator><dc:creator>Kuyrukluyildiz, Ufuk</dc:creator><dc:creator>Karavas, Erdal</dc:creator><dc:creator>Tas, Hakan Gokalp</dc:creator><dc:subject>Case report</dc:subject><dc:subject>COVID-19</dc:subject><dc:subject>Intensive care</dc:subject><dc:subject>Pneumonia</dc:subject><dc:subject>Tromboembolia</dc:subject><dc:subject>Critical Care</dc:subject><dc:subject>Deep Sedation</dc:subject><dc:subject>Humans</dc:subject><dc:subject>Intracranial Thrombosis</dc:subject><dc:subject>Male</dc:subject><dc:subject>Middle Aged</dc:subject><dc:subject>azithromycin</dc:subject><dc:subject>C reactive protein</dc:subject><dc:subject>creatine kinase</dc:subject><dc:subject>D dimer</dc:subject><dc:subject>enoxaparin</dc:subject><dc:subject>favipiravir</dc:subject><dc:subject>ferritin</dc:subject><dc:subject>fibrinogen</dc:subject><dc:subject>hydroxychloroquine</dc:subject><dc:subject>methylprednisolone</dc:subject><dc:subject>midazolam</dc:subject><dc:subject>oseltamivir</dc:subject><dc:subject>procalcitonin</dc:subject><dc:subject>proton pump inhibitor</dc:subject><dc:subject>rocuronium</dc:subject><dc:subject>tocilizumab</dc:subject><dc:subject>adult</dc:subject><dc:subject>adult respiratory distress syndrome</dc:subject><dc:subject>Article</dc:subject><dc:description>Although the severity of coronavirus disease 2019 (COVID-19) being more frequently related to acute respiratory distress syndrome and acute cardiac and renal injuries, thromboembolic events have been increasingly reported. Acute respiratory distress syndrome due to SARS-CoV-2 (Severe Acute Respiratory Syndrome-Corona Virus 2) often requires intensive care follow-up. As well as respiratory failure, the SARS-CoV-2 may cause central nervous system (CNS) involvement. The pandemic has raised many challenges in managing critically ill older adults, a population preferentially killed by COVID-19. The mortality and morbidity rates are extremely high in critically ill patients with COVID-19. Recent studies have reported the potential development of a hypercoagulable state in COVID-19. Viral infections and hypoxia may cause these state. It is increasingly reported that thromboembolic events are associated with a poor prognosis. Due to these thromboembolic complications, COVID-19 patients often have neurological symptoms. These symptoms may not be observed in intensive care patients who are sedated. We report one case who was sedated COVID-19 pneumonia and who was later diagnosed with cerebral venous thrombosis with cranial imaging when he could not awaken even though sedation was discontinued. Since COVID-19 causes intense thrombotic susceptibility due to cytokine storm, cerebrovascular thromboembolic complications associated with COVID-19 infection should be considered first and foremost for unconsciousness ventilated patients. Severe and potentially cerebral thrombosis may prolong the patient´s stay in intensive care. © Edhem Unver et al.</dc:description><dc:publisher>African Field Epidemiology Network</dc:publisher><dc:date>2021</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/13284</dc:identifier><dc:identifier>https://doi.org/10.11604/pamj.2021.38.373.29034</dc:identifier><dc:identifier>1937-8688</dc:identifier><dc:language>en</dc:language><dc:relation>Pan African Medical Journal</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/13284</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>